Table 2.
Comparison of parameters among three groups by paired-samples t test
| Index | Group | Before intervention | After intervention | t value | P value |
| BMI | Group1 | 29.81 ± 2.41 | 29.83 ± 2.32 | -0.339 | 0.736 |
| Group2 | 29.61 ± 1.48 | 27.18 ± 1.83 | 12.892 | 0 | |
| Group3 | 29.37 ± 3.11 | 27.92 ± 3.29 | 8.034 | 0 | |
| ZBMI | Group1 | 3.53 ± 1.17 | 3.55 ± 1.16 | -1.765 | 0.086 |
| Group2 | 3.02 ± 0.39 | 2.15 ± 0.64 | 16.356 | 0 | |
| Group3 | 3.44 ± 1.57 | 2.57 ± 1.57 | 9.438 | 0 | |
| ALT | Group1 | 144.77 ± 26.73 | 144.82 ± 25.51 | -0.076 | 0.94 |
| Group2 | 152.26 ± 49.30 | 63.68 ± 23.38 | 9.654 | 0 | |
| Group3 | 139.97 ± 19.82 | 73.28 ± 10.11 | 13.219 | 0 | |
| AST | Group1 | 86.63 ± 21.54 | 85.73 ± 19.60 | 1.017 | 0.316 |
| Group2 | 93.26 ± 38.94 | 45.09 ± 19.18 | 6.699 | 0 | |
| Group3 | 78.55 ± 23.11 | 45.80 ± 6.66 | 6.9 | 0 | |
| TG | Group1 | 1.44 ± 0.35 | 1.46 ± 0.31 | -0.69 | 0.494 |
| Group2 | 1.38 ± 0.38 | 0.99 ± 0.37 | 3.851 | 0.001 | |
| Group3 | 1.51 ± 0.33 | 1.27 ± 0.28 | 4.6 | 0 | |
| THCO | Group1 | 4.70 ±1.18 | 4.69 ± 1.09 | 0.204 | 0.84 |
| Group2 | 4.83 ± 0.92 | 4.54 ± 0.98 | 2.783 | 0.012 | |
| Group3 | 4.61 ± 1.03 | 4.23 ± 0.82 | 2.24 | 0.038 | |
| FBG | Group1 | 4.26 ± 0.42 | 4.26 ± 0.32 | -0.046 | 0.964 |
| Group2 | 4.15 ± 0.39 | 4.13 ± 0.42 | 0.154 | 0.879 | |
| Group3 | 4.22 ± 0.43 | 4.08 ± 0.41 | 1.11 | 0.279 | |
| FINS | Group1 | 15.50 ± 2.10 | 15.71 ± 2.19 | -0.941 | 0.353 |
| Group2 | 15.54 ± 4.50 | 8.53 ± 4.08 | 4.322 | 0 | |
| Group3 | 15.42 ± 1.10 | 8.77 ± 2.46 | 10.26 | 0 | |
| HOMA-IR | Group1 | 2.93 ± 0.44 | 2.97 ± 0.51 | -0.886 | 0.382 |
| Group2 | 2.87 ± 0.88 | 1.63 ± 0.92 | 3.579 | 0.002 | |
| Group3 | 2.89 ± 0.32 | 1.62 ± 0.59 | 8.08 | 0 |
BMI: Body mass index; ALT: Plasma alanine aminotransferase; AST: aspartate aminotransferase; TG: Triglyceride; TCHO: Total cholesterol; FBG: Fasting blood glucose; FINS: Fasting serum insulin; HOMA-IR: Homeostasis model assent-insulin resistance.